Economic analysis of aldosterone blockade with eplerenone in patients with heart failure after acute myocardial infarction: Results from EPHESUS

被引：0
|
作者：
Weintraub, WS
Zhang, Z
Mahoney, EM
Spertus, J
Tooley, J
Akhras, K
Willke, R
Pitt, B
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
[2] Mid Amer Heart Inst, Kansas City, MO USA
[3] Pfizer, New York, NY USA
来源：
CIRCULATION | 2003年 / 108卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1603
引用
收藏
页码：342 / 342
页数：1
相关论文
共 50 条
  • [21] Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trial
    Adamopoulos, Chris
    Ahmed, Ali
    Fay, Renaud
    Angioi, Michael
    Filippatos, Gerasimos
    Vincent, John
    Pitt, Bertram
    Zannad, Faiez
    EUROPEAN JOURNAL OF HEART FAILURE, 2009, 11 (11) : 1099 - 1105
  • [22] Eplerenone in Patients With Acute Myocardial Infarction Complicated by Heart Failure Response
    Pitt, Bertram
    HYPERTENSION, 2008, 52 (06) : E148 - E148
  • [23] Baseline predictors of total follow-up costs in patients with heart failure after acute myocardial infarction: Results from EPHESUS
    Zhang, ZF
    Abramson, J
    Spertus, JA
    Pitt, B
    Weintraub, WS
    CIRCULATION, 2005, 111 (20) : E318 - E318
  • [24] Cost Effectiveness of Eplerenone in Patients with Heart Failure after Acute Myocardial Infarction Who were Taking Both ACE Inhibitors and β-Blockers Subanalysis of the EPHESUS
    Zhang, Zefeng
    Mahoney, Elizabeth M.
    Kolm, Paul
    Spertus, John
    Caro, Jaime
    Willke, Richard
    Weintraub, William S.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2010, 10 (01) : 55 - 63
  • [25] Aldosterone blockade in patients with acute myocardial infarction
    Pitt, B
    CIRCULATION, 2003, 107 (20) : 2525 - 2527
  • [26] Determinants and Consequences of Renal Function Variations With Aldosterone Blocker Therapy in Heart Failure Patients After Myocardial Infarction Insights From the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study
    Rossignol, Patrick
    Cleland, John G. F.
    Bhandari, Sunil
    Edu, M. Clin
    Tala, Stephane
    Gustafsson, Finn
    Fay, Renaud
    Lamiral, Zohra
    Dobre, Daniela
    Pitt, Bertram
    Zannad, Faiez
    CIRCULATION, 2012, 125 (02) : 271 - 279
  • [27] The effect of eplerenone on all-cause mortality and heart failure hospitalization in the Eplerenone Post-acute myocardial infarction Heart failure Efficacy and Survival Study (EPHESUS)
    Zannad, F
    Gheorghiade, M
    Krum, H
    Chu, TC
    Patni, R
    Pitt, B
    JOURNAL OF CARDIAC FAILURE, 2004, 10 (04) : S76 - S76
  • [28] History of hypertension and eplerenone in patients with acute myocardial infarction complicated by heart failure
    Pitt, Bertram
    Ahmed, Ali
    Love, Thomas E.
    Krum, Henry
    Nicolau, Jose
    Cardoso, Jose S.
    Parkhomenko, Alexander
    Aschermann, Michael
    Corbalan, Ramon
    Solomon, Henry
    Shi, Harry
    Zannad, Faiez
    HYPERTENSION, 2008, 52 (02) : 271 - 278
  • [29] Patient Health Status and Costs in Heart Failure Insights From the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS)
    Chan, Paul S.
    Soto, Gabriel
    Jones, Philip G.
    Nallamothu, Brahmajee K.
    Zhang, Zefeng
    Weintraub, William S.
    Spertus, John A.
    CIRCULATION, 2009, 119 (03) : 398 - 407
  • [30] Serum sodium and eplerenone use in patients with a myocardial infarction and left ventricular dysfunction or heart failure: insights from the EPHESUS trial
    Martens, Pieter
    Ferreira, Joao Pedro
    Vincent, John
    Abreu, Paula
    Busselen, Martijn
    Mullens, Wilfried
    Tang, Wilson W. H.
    Bohm, Michael
    Pitt, Bertram
    Zannad, Faiez
    Rossignol, Patrick
    CLINICAL RESEARCH IN CARDIOLOGY, 2022, 111 (04) : 380 - 392
12345